A placebo-controlled trial of Korean red ginseng extract for preventing Influenza-like illness in healthy adults

Table 1 A brief study schedule at every visit.

	Screening Visit 1	Baseline Visit 2	Visit 3	Visit 4	Visit 5	Follow up (Visit 6)
	D-21 ~D-1	Week 0 D0	Week 4 D28	Week 8 D56	Week 12 D84	Week 17 D119
*Informed consent form*	◯
*Demographic information taking* ¹	◯
*Medical history taking*	◯	◯	◯	◯	◯
*Inclusion/exclusion criteria check*	◯	◯
*Physician examination* ²	◯				◯
*Vital sign measurement*	◯	◯	◯	◯	◯
*Concomitant drugs check*	◯	◯	◯	◯	◯
*Electrocardiogram(ECG)*	◯				◯
*Questionnaires for symptoms related to ILI* ³	◯	◯	◯	◯	◯	◯
*Laboratory test* ⁴	◯				◯
*Study product distribution*		◯	◯	◯
*Compliance checking*			◯	◯	◯
*Adverse event monitoring*			◯	◯	◯	◯

^◯ : Item need to be performed during the visit
¹ Sex, date of birth, age, contact address and phone number
² Include present illness, past history taking
³ Frequency of ILI symptom onset, severity of ILI symptoms, and duration of ILI symptoms
⁴ Blood test (WBC, RBC, hemoglobin, hematocrit, platelets count, AST, ALT, ALP, gamma-GTP, albumin, BUN, creatinine, glucose, total bilirubin, total protein), urine test (specific gravity, pH, protein, ketone, glucose, bilirubin, urobilinogen, nitrite, microscopic (RBC, WBC))

ISSN: 2662-7671